148 related articles for article (PubMed ID: 20040095)
1. Autonomous growth potential of leukemia blast cells is associated with poor prognosis in human acute leukemias.
Yan Y; Wieman EA; Guan X; Jakubowski AA; Steinherz PG; O'Reilly RJ
J Hematol Oncol; 2009 Dec; 2():51. PubMed ID: 20040095
[TBL] [Abstract][Full Text] [Related]
2. Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice.
Yan Y; Salomon O; McGuirk J; Dennig D; Fernandez J; Jagiello C; Nguyen H; Collins N; Steinherz P; O'Reilly RJ
Blood; 1996 Oct; 88(8):3137-46. PubMed ID: 8874214
[TBL] [Abstract][Full Text] [Related]
3. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
[TBL] [Abstract][Full Text] [Related]
4. Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
Uckun FM; Sather H; Reaman G; Shuster J; Land V; Trigg M; Gunther R; Chelstrom L; Bleyer A; Gaynon P
Blood; 1995 Feb; 85(4):873-8. PubMed ID: 7849309
[TBL] [Abstract][Full Text] [Related]
5. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
Rombouts WJ; Martens AC; Ploemacher RE
Leukemia; 2000 May; 14(5):889-97. PubMed ID: 10803522
[TBL] [Abstract][Full Text] [Related]
6. Propagation of human blastic myeloid leukemias in the SCID mouse.
Sawyers CL; Gishizky ML; Quan S; Golde DW; Witte ON
Blood; 1992 Apr; 79(8):2089-98. PubMed ID: 1562735
[TBL] [Abstract][Full Text] [Related]
7. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
Cesano A; Hoxie JA; Lange B; Nowell PC; Bishop J; Santoli D
Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
[TBL] [Abstract][Full Text] [Related]
8. Childhood acute myeloid leukemia in mice with severe combined immunodeficiency.
Chelstrom LM; Gunther R; Simon J; Raimondi SC; Krance R; Crist WM; Uckun FM
Blood; 1994 Jul; 84(1):20-6. PubMed ID: 8018918
[TBL] [Abstract][Full Text] [Related]
9. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.
Ailles LE; Gerhard B; Kawagoe H; Hogge DE
Blood; 1999 Sep; 94(5):1761-72. PubMed ID: 10477702
[TBL] [Abstract][Full Text] [Related]
10. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
11. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
12. AC133 antigen as a prognostic factor in acute leukemia.
Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
[TBL] [Abstract][Full Text] [Related]
13. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
[TBL] [Abstract][Full Text] [Related]
14. Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice.
Uckun FM; Waurzyniak BJ; Sensel MG; Chelstrom L; Crotty ML; Gaynon PS; Reaman GH
Leuk Lymphoma; 1998 Jul; 30(3-4):269-77. PubMed ID: 9713959
[TBL] [Abstract][Full Text] [Related]
15. Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Chelstrom LM; Gunther R; Ryan M; Simon J; Carroll AJ; Tuel-Ahlgren L; Crist WM
Blood; 1994 Aug; 84(3):859-65. PubMed ID: 8043867
[TBL] [Abstract][Full Text] [Related]
16. Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID mice.
Palucka AK; Scuderi R; Porwit A; Jeha S; Gruber A; Björkholm M; Beran M; Pisa P
Leukemia; 1996 Mar; 10(3):558-63. PubMed ID: 8642875
[TBL] [Abstract][Full Text] [Related]
17. Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice.
Steele JP; Clutterbuck RD; Powles RL; Mitchell PL; Horton C; Morilla R; Catovsky D; Millar JL
Blood; 1997 Sep; 90(5):2015-9. PubMed ID: 9292537
[TBL] [Abstract][Full Text] [Related]
18. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.
Paczulla AM; Dirnhofer S; Konantz M; Medinger M; Salih HR; Rothfelder K; Tsakiris DA; Passweg JR; Lundberg P; Lengerke C
Haematologica; 2017 May; 102(5):854-864. PubMed ID: 28183848
[TBL] [Abstract][Full Text] [Related]
19. Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias.
McGuirk J; Yan Y; Childs B; Fernandez J; Barnett L; Jagiello C; Collins N; O'Reilly RJ
Bone Marrow Transplant; 1998 Aug; 22(4):367-74. PubMed ID: 9722072
[TBL] [Abstract][Full Text] [Related]
20. Two serologic markers to monitor the engraftment, growth, and treatment response of human leukemias in severe combined immunodeficient mice.
Arguello F; Sterry JA; Zhao YZ; Alexander MR; Shoemaker RH; Cohen HJ
Blood; 1996 May; 87(10):4325-32. PubMed ID: 8639792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
